Advertisement
New Zealand markets closed
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NZD/USD

    0.5943
    +0.0009 (+0.15%)
     
  • ALL ORDS

    7,947.50
    +9.60 (+0.12%)
     
  • OIL

    83.46
    +0.10 (+0.12%)
     
  • GOLD

    2,343.30
    +1.20 (+0.05%)
     

Does This Biotech Have the Secret to Conquering Covid Variants?

Does This Biotech Have the Secret to Conquering Covid Variants?

Gritstone Bio (NASDAQ: GRTS) is far from being the first to the coronavirus vaccine finish line. The biotech company's vaccine candidate just began phase 1 trials this year. Gritstone's clinical trials are in the earliest stage.